This inventor holds 7 USPTO granted patents, plus 2 CIPO patents. Top assignees: The Liposome Company, Inc., Transave Limited, Elan Pharmaceuticalstechnologies, Inc.. Active years: 2000-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Princeton, NJ (US) (2002)
- Princeton Junction, NJ (US) (2000 - 2009)
Company Filing History:
Years Active: 2000-2009
Title: The Innovative Contributions of Paul R. Meers
Introduction
Paul R. Meers is a notable inventor based in Princeton Junction, NJ, with a significant portfolio of seven patents. His work primarily focuses on advancements in liposomal delivery systems, which have important applications in the field of biomedicine.
Latest Patents
Among his latest patents is the invention titled "Encapsulation of Bioactive Complexes in Liposomes." This invention provides a method to prepare liposome-encapsulated bioactive agents, such as nucleic acids. It involves the complexation of bioactive agents in reverse micelles prior to forming liposomes, along with methods for using these liposomes to deliver nucleic acids to cells. Another significant patent is the "Modular Targeted Liposomal Delivery System." This patent describes a liposome that includes a fusogenic liposome, a linking moiety, and a targeting moiety. The fusogenic liposome encapsulates contents within a lipid bilayer, while the linking moiety is electrostatically bound to the lipid bilayer, and the targeting moiety is covalently bound to the linking moiety.
Career Highlights
Throughout his career, Paul R. Meers has worked with prominent companies in the pharmaceutical and biotechnology sectors, including The Liposome Company, Inc. and Transave Limited. His contributions to these organizations have been instrumental in advancing liposomal technology.
Collaborations
Paul has collaborated with notable professionals in his field, including Andrew S. Janoff and Charles Pak. Their combined expertise has furthered the development of innovative liposomal delivery systems.
Conclusion
Paul R. Meers is a distinguished inventor whose work in liposomal technology has made significant contributions to biomedicine. His patents reflect a commitment to advancing methods for delivering bioactive agents effectively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile